Clinical Trials
61 trialsSingle Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
University of Texas Southwestern Medical Center
N01-A-PICIT-GI
Peking University People's Hospital
FUDOSE
UNICANCER
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
M.D. Anderson Cancer Center
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
Memorial Sloan Kettering Cancer Center
ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
Abramson Cancer Center at Penn Medicine
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Brigham and Women's Hospital
ACT-GI
Massachusetts General Hospital
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer
Mayo Clinic
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer
Georgetown University
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers
Emory University
CAPTIV-8
British Columbia Cancer Agency
ONS in Gastrointestinal Cancer Patients Undergoing Chemotherapy
Beni-Suef University
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
Thomas Jefferson University
Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases
China Medical University, China
NEONEC
GERCOR - Multidisciplinary Oncology Cooperative Group
ctDNA-RECIST
Aarhus University Hospital
COMBIGaPP
Isala
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
University of Chicago
A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers
Olivia Newton-John Cancer Research Institute
SGM-CBM
Leiden University Medical Center
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Nanjing First Hospital, Nanjing Medical University
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
SCRI Development Innovations, LLC
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
ROME
Fondazione per la Medicina Personalizzata
HYPERION
Fudan University
TOFFEE
University of Edinburgh
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
ALTER-E005
Jiangxi Provincial Cancer Hospital
Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations
Tianjin Medical University Cancer Institute and Hospital
A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy
Zhejiang Cancer Hospital
ALTER-C-002
Zhejiang University
An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal
Harbin Medical University
X7-7
University of Kansas Medical Center
Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer
M.D. Anderson Cancer Center
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
PALAESTRA
Lund University Hospital
CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater
M.D. Anderson Cancer Center
HYPAZ
Cambridge University Hospitals NHS Foundation Trust
Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas
M.D. Anderson Cancer Center
HIPEC/IPHC
Bay Area Gynecology Oncology
IXOGoo1
AHS Cancer Control Alberta
EMERGE
Royal Marsden NHS Foundation Trust
ACUFOCIN
The Christie NHS Foundation Trust
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)
Shenzhen People's Hospital
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
FluoHeart
Helsinki University Central Hospital
Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers
University of Utah
EVERLAR
Grupo Espanol de Tumores Neuroendocrinos